Douglas H. Johnson: a tribute.

s and letters 1. Johnson, D.H., Bourne, W.M., Campbell, R.J., 1981 Mar. Ultrastructure of Descemet’s membrane in Fuchs’ dystrophy. Investig. Ophthalmol. Vis. Sci. 20, 114 (abstract 1). 2. Allen, R.C., Johnson, D.H., Epstein, D.L., 1982. A long-term clinical trial of betaxolol in glaucoma patients. Ophthalmology 89, 191. 3. Johnson, D.H., Richardson, T.M., Epstein, D.L., 1983. Trabecular meshwork phagocytosis: long-term response. Investig. Ophthalmol. Vis. Sci. 24 (Suppl.), 136. 4. Johnson, M.C., Johnson, D.H., Kamm, R.D., 1983. Filtration characteristics of the aqueous outflow system. Investig. Ophthalmol. Vis. Sci. 24 (Suppl.), 86. Please cite this article in press as: Johnson, M., Michael P. Fautsch, D j.exer.2008.11.009 5. Johnson, D.H., 1985 Mar. Does pigmentation of the trabecular meshwork affect cellularity? Investig. Ophthalmol. Vis. Sci. 26 (Suppl.), 4 (abstract 3). 6. Johnson, D.H., Tschumper, R.C., 1986. An in situ method for culture of human trabecular meshwork. In: Int. Congr. Eye Res. IV, p. 184. 7. Johnson, D.H., 1986 Mar. Do trabecular meshwork cells replicate? Investig.Ophthalmol. Vis. Sci. 27 (Suppl.), 210 (abstract 2). 8. Johnson, D.H., Tschumper, R.C., 1987 Mar. The effect of organ culture on human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 28 (Suppl.), 283 (abstract 3). 9. Tschumper, R.C., Johnson, D.H., 1987 Mar. A new method for organ culture of human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 28 (Suppl.), 133. 10. Bourne, W.M., Brunette, I., Johnson, D.H., Maguire, L.J., 1989. Long-term corneal perfusion: a research model for donated human eyes unsuitable for transplantation. In: 28th Annual Scientific Session, Eye Bank Association of America, p. 5. 11. Buller, C.R., Johnson, D.H., 1989. Human trabecular meshwork phagocytosis. Investig. Ophthalmol. Vis. Sci. 30 (Suppl.), 223. 12. Johnson, D.H., Bradley, J.M., Acott, T.S., Fauss, D.J., Polansky, J.R., 1989. The effect of steroids on human trabecular meshwork in perfusion organ culture. Investig. Ophthalmol. Vis. Sci. 30 (Suppl.), 223. 13. Tschumper, R.C., Johnson, D.H., Acott, T.S., Knepper, P.A., 1989. Glycosaminoglycans of human TM in organ culture. Investig. Ophthalmol. Vis. Sci. 30 (Suppl.), 224. 14. Johnson, D.H.,1990. Studies on human trabecularmeshwork in organ culture. In: Int. Congr. Eye Res. VI, p. 81. 15. Tschumper, R.C., Sloan, L.M., Rosenblatt, J.E., Johnson, D.H., 1990. A human in vitro model for acanthamoeba keratitis. Investig. Ophthalmol. Vis. Sci. 31 (Suppl.), 419. 16. Buller, C.R., Johnson, D.H., Campbell, R.J., 15 Mar 1991. Do segmental variations exist in the TM of glaucomatous eyes? Investig. Ophthalmol. Vis. Sci. 32, 943 (abstract 1347-85). 17. Johnson, D.H., Tschumper, R.C., 15 Mar 1991. Ethacrynic acid: outflow effects and toxicity in human trabecular meshwork in perfusion organ culture. Investig. Ophthalmol. Vis. Sci. 32, 1257 (abstract 2885). 18. Bahler, C.K., Johnson, D.H., 1992. The porcine eye as amodel for aqueous outflow perfusion studies. Investig. Ophthalmol. Vis. Sci. 33 (Suppl.), 1161. 19. Buller, C.R., Johnson, D.H., 1992. Computerized morphometric analysis of JCT: light microscopy vs transmission electron microscopy. Investig. Ophthalmol. Vis. Sci. 33 (Suppl.), 1165. 20. Flugel, C., Wiesand, M., Lutjen-Drecoll, E., Johnson, D., 1992. Regional differences in primary open angle glaucomatous eyes. In: Tenth International Congress of Eye Research X, p. 67. 21. Johnson, D.H., Knepper, P., 1992. The effects of ascorbate and dexamethasone on GAGs, IOP, and ultrastructure of human TM in organ culture. Investig. Ophthalmol. Vis. Sci. 33 (Suppl.), 1164. 22. Johnson, D.H., Knepper, P.A., 1992. The effects of dexamethasone on GAGs, IOP, and ultrastructure of human TM in organ culture. In: Tenth International Congress of Eye Research X, p. 81. 23. Kimpel, M.W., Johnson, D.H., 1992. Factors influencing in vivo trabecular cell replication in cats. Investig. Ophthalmol. Vis. Sci. 33 (Suppl.), 1164. 24. Buller, C.R., Johnson, D.H., 15 Mar 1993. Computerized morphometric analysis of JCT: circumferential differences in normal and glaucomatous eyes. Investig. Ophthalmol. Vis. Sci. 34, 1384 (abstract 3362-8). 25. Johnson, D.H., 1994. Cytochalasin D increases outflow facility in the human eye in perfusion organ culture. In: Joint European Research Meetings in Ophthalmology and Vision, p. 51. ouglas H. Johnson: A tribute, Exp. Eye. Res. (2009), doi:10.1016/ M. Johnson, M.P. Fautsch / Experimental Eye Research xxx (2009) 1–11 9 ARTICLE IN PRESS 26. Buller, C.R., Camp, J.J., Johnson, D.H., 15 Mar 1994. Three dimensional analysis of trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 35 (4), 1557 (abstract 1417) Annual Meeting Abstract Issue. 27. Johnson, D.H., 15 Mar 1994. Human trabecular cell survival is dependent upon perfusion rate. Investig. Ophthalmol. Vis. Sci. 35 (4), 2082 (abstract 3825) Annual Meeting Abstract Issue. 28. Hann, C.R., Camp, J.J., Johnson, D.H., 1995. 3-D analysis of channel architecture in the trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 36 (4), S195. 29. Russell, P., Johnson, D.H., 1995. Two dimensional gel electrophoresis of segments of human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 36, S129. 30. Ten Hulzen, R.D., Johnson, D.H., 1995. Quantitative analysis of the juxtacanalicular tissue and Schlemm’s canal using two different fixation pressures. Investig. Ophthalmol. Vis. Sci. 36 (4), S730. 31. Johnson, D.H., 1996. Cytochalasin D increases outflow facility in the human eye in perfusion organ culture. Investig. Ophthalmol. Vis. Sci. 37 (3), S894. 32. Lutjen-Drecoll, E., Johnson, D., Gottanka, J., Flugel-Koch, C., 1996. Changes in the trabecular meshwork of human eyes after long term treatment with steroids. Investig. Ophthalmol. Vis. Sci. 37, S444. 33. Matsumoto, Y., Bahler, C.K., Hann, C.R., Johnson, D.H., 1996. Dexamethasone decreases phagocytosis in human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 37 (3), S825. 34. Tamm, E.R., Russell, P., Johnson, D.H., Piatigorsky, J., 1996. Trabecular meshwork accumulates alpha B-crystallin in response to heat shock oxidative stress and culture conditions. Investig. Ophthalmol. Vis. Sci. 37, S152. 35. Borras, T., Masumoto, Y., Johnson, D.H., 15 Mar 1997. Gene transfer into human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 38 (4), S452 (abstract 2122). 36. Gottanka, J., Flugel-Koch, J., Martus, P., Johnson, D.H., LutjenDrecoll, E., 15 Mar 1997. Correlation of severity of optic nerve damage with changes in the trabecular meshwork in different forms of glaucoma. Investig. Ophthalmol. Vis. Sci. 38 (4), S160 (abstract 794). 37. Hattenhauer, M.G., Johnson, D.H., Herman, D.C., Yawn, B.P., Butterfield, L., Ing, H.H., Hodge, D.O., Gray, D.T., 15 Mar 1997. Probability of blindness from open angle glaucoma. Investig. Ophthalmol. Vis. Sci. 38 (4), S729 (abstract 3362). 38. Johnson, D.H., 15 Mar 1997. Schlemm’s canal in POAG and PEX at varying stages of severity. Investig. Ophthalmol. Vis. Sci. 38 (4), S562 (abstract 2616). 39. Bintareef, R.M., Hattenhauer, M.G., Herman, D.C., Johnson, D.H., Ing, H.H., Hodge, D.O., 1998. Probability of success of trabeculectomy with and without mitomycin C. Investig. Ophthalmol. Vis. Sci. 39 (4), S248. 40. Brilakis, H.S., Johnson, D.H., 1998. What is the lifespan of a giant vacuole? Investig. Ophthalmol. Vis. Sci. 39 (4), S487. 41. Matsumoto, Y., Mori, K., Kinoshita, S., Johnson, D.H., 1998. Dexamethasone increases the volume and DNA content of the nucleus in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 39, S704. 42. Rohde, E., Tomlinson, A., Naylor, S., Johnson, D.H., 1998. Mass spectrometric analysis of aqueous humor and pseudoexfoliation material. Investig. Ophthalmol. Vis. Sci. 39 (4), S490. 43. Welge-Luben, U., May, C.A., Polansky, J.R., Nguyen, T.D., Bloemendal, H., Johnson, D.H., Lutjen-Drecoll, E., 1998 Jul. Stress proteins and TIGR in normal and glaucomatous trabecular meshwork. Exp. Eye Res. 67 (Suppl. 1), S134 (abstract 429). 44. Hann, C.R., Johnson, D.H., Springett, M.J., 15 Mar 1999. Immunogold labeling of type IV collagen in the trabecular Please cite this article in press as: Johnson, M., Michael P. Fautsch, D j.exer.2008.11.009 meshwork of normal and glaucomatous eyes. Investig. Ophthalmol. Vis. Sci. 40 (4), S667. 45. Johnson, D.H., Bahler, C.K., 15 Mar 1999. Heparitinase increases outflow facility in the human eye. Investig. Ophthalmol. Vis. Sci. 40 (4), S504. 46. Parc, C.E., Johnson, D.H., 15 Mar 1999. Do anatomic factors influence the formation of giant vacuoles? Investig. Ophthalmol. Vis. Sci. 40 (4), S505. 47. Wang, X., Bahler, C.K., Johnson, D.H.,15Mar 1999. mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 40 (4), S667. 48. Hattenhauer, M.G., Johnson, D.H., Herman, D.C., Hodge, D.O., Gray, D.T., 2000. Half empty or half full? Arch. Ophthalmol.118, 861–862. 49. Herndon, L.W., Johnson, D.H., Coleman, A.L., Lee, P.P., 2000. Factors associated with vision loss in glaucoma. Investig. Ophthalmol. Vis. Sci. 40, S280. 50. Johnson, D.H., Wang, X., 2000 Feb. Localization of the TIGRproducing cells in human trabecular meshwork by in situ hybridization. J. Glaucoma 9 (1), 109 (abstract 16). 51. Fautsch, M.P., Bahler, C.K., Jewison, D.J., Johnson, D.H., 15 Mar 2000. rTIGR/MYOC increases outflow resistance in the human anterior segment. Investig. Ophthalmol. Vis. Sci. 41 (4), S762. 52. Hann, C.R., Johnson, D.H., Springett, M.J., 15 Mar 2000. Immunogold labeling of fibronectin and laminin in the trabecular meshwork of normal and glaucomatous eyes. Investig. Ophthalmol. Vis. Sci. 41 (4), S504. 53. Johnson, D.H., Parc, C.E., Oliver, J., Hattenhauer, M.G., Hodge, D.O., 15 Mar 2000. The long-term outcome of glaucoma filtration surgery. Investig. Ophthalmol. Vis. Sci. 41 (4), S518. 54. Oliver, J.E., Johnson, D.H., Hattenhauer, M.G., Hodge, D.O., Herman, D.C., 15 Mar 2000. Cumulative patient survival rates after diagnosis of open angle glaucoma, and legal blindness secondary to open angle glaucoma in Olmsted County, Minnesota. Investig. Ophthalmol. Vis. Sci. 41 (4), S280. 55. Wang, X., Johnson, D.H., 15 Mar 2000. mRNA in situ hybridization of perlecan and laminin gamma1 in human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 41 (4), S504. 56. Fautsch, M.P., Bahler, C.K., Jewison, D.J., Johnson, D.H., 16 Oct 2000. MYOC increases outflow resistance in the human anterior segment. In: Fourteenth International Congress of Eye Research, p. S51. 57. Johnson, D.H., Bahler, C., 19 Oct 2000. Glycosaminoglycans, the extracellular matrix, and aqueous outflow. In: Fourteenth International Congress of Eye Research, p. S156. 58. Wheelock, R.H., Johnson, D., Borras, T., Russell, P., 19 Oct 2000. Microarray comparison of gene expression changes in human trabecular meshwork cells and perfused trabecular meshwork after chronic glucocorticoid treatment. In: Fourteenth International Congress of Eye Research, p. S172. 59. Gottanka, J., Johnson, D.H., Lutjen-Drecoll, E., 2001. Why is intraocular pressure elevated in pigmentary glaucoma? Investig. Ophthalmol. Vis. Sci. 42, S145. 60. Peters, D.M., Santas, A.J., Lui, X., Polansky, P.L., Kaufman, E.R., Tamm, D., Johnson, D., 2001. The heparin II domain of fibronectin modulates aqueous outflow: effect on trabecular meshwork matrix and adhesions. Investig. Ophthalmol. Vis. Sci. 42, S730. 61. Fautsch, M.P., Johnson, D.H., 15 Mar 2001. Evidence of MYOC– MYOC interactions. Investig. Ophthalmol. Vis. Sci. 42 (4), S144. 62. Good, M.S., Krebsbach, V., Loewen, N., Poeschla, E.M., Johnson, D.H., 15 Mar 2001. Transduction of retinal ganglion cells in culture using feline immunodeficiency virus. Investig. Ophthalmol. Vis. Sci. 42 (4), S411. 63. Loewen, N., Fautsch, M.P., Xu, R., Cameron, J.D., Johnson, D.H., Poeschla, E.M., 15 Mar 2001. Comparison of lentiviral, type C ouglas H. Johnson: A tribute, Exp. Eye. Res. (2009), doi:10.1016/ M. Johnson, M.P. Fautsch / Experimental Eye Research xxx (2009) 1–11 10 ARTICLE IN PRESS retroviral, and adenoviral vectors for transduction of human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 42 (4), S731. 64. Bahler, C.K., Fautsch, M.P., Hann, C.R., Johnson, D.H., 2002. H-7 increases outflow facility in human cultured anterior segments. In: Annual Meeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 1031). 65. Fautsch, M.P., Silva, A.O., Johnson, D.H., 2002. Expression of galectin-1 and galectin-3 in the human rabecular meshwork. In: Annual Meeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 1057). 66. Hann, C.R., Bahler, C.K., Fautsch, M.P., Johnson, D.H., 2002. Effect of RGD peptide on outflow facility in human anterior segments in perfusion organ culture. In: AnnualMeeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 1024). 67. Jeng, S.M., Karger, R.A., Johnson, D.H., Hodge, D.O., Burke, J., Good, M.S., 2002. Conversion rate of pseudoexfoliation syndrome to pseudoexfoliation glaucoma in a populationbased study. In: Annual Meeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 2947). 68. Johnson, D.H., 2002. Histologic findings after laser trabeculoplasty in glaucomatous eyes. In: Annual Meeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 3958). 69. Karger, R.A., Jeng, S.M., Johnson, D.H., Hodge, D.O., Burke, J., Good, M.S., 2002. Incidence of pseudoexfoliation syndrome in Olmsted County, Minnesota. In: Annual Meeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 3321). 70. Loewen, N.A., Fautsch, M.P., Bahler, C.K., Johnson, D.H., Poeschla, E.M., 2002. Effects of FIV-based lentiviral vector transduction of trabecular meshwork on aqueous outflow facility and in vivo monitoring of expression in cats. In: Annual Meeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 3960). 71. Siddiqui, Y., Hodge, D.O., Cameron, J.D., Johnson, D.H., 2002. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? In: Annual Meeting of the Association for Research in Vision and Ophthalmology 2002 (abstract 285). 72. Quiram, P.A., Hodge, D.O., Burke, J., Johnson, D.H., Good, M.S., 8 May 2002. Congenital glaucoma: a population-based study and analysis of cases at the Mayo Clinic. Investig. Ophthalmol. Vis. Sci. (abstract 3320). 73. Bahler, C.K., Fautsch, M.P., Acott, T.S., Johnson, D.H., 2003. Factors influencing outflow facility in cultured human anterior segments. In: Arvo Annual Meeting Abstract Search & Program Planner 2003 (abstract 1156). 74. Fautsch, M.P., Vrabel, A.M., Bahler, C.K., Johnson, D.H., 2003. How do protein expression profiles from the human anterior segment culture model compare to the in vivo state? In: Arvo Annual Meeting Abstract Search & Program Planner 2003 (abstract 3165). 75. Karger, R.A., Jeng, S.M., Hodge, D.O., Johnson, D.H., Good, M.S., 2003. Cataract surgery in patients with pseudoexfoliation syndrome in Olmsted County, Minnesota. In: Arvo Annual Meeting Abstract Search & Program Planner 2003 (abstract 3422). 76. Loewen, N.A., Teo, W., Fautsch, M.P., Bahler, C.K., Johnson, D.H., Poeschla, E.M., 2003. Transgene-specific toxicity in lentiviral vector – transduced feline tm in vivo. In: Arvo Annual Meeting Abstract Search & Program Planner 2003 (abstract 1147). 77. Poeschla, E.M., Fautsch, M.P., Loewen, N., Teo, W., Johnson,Search & Program Planner 2003 (abstract 1147). 77. Poeschla, E.M., Fautsch, M.P., Loewen, N., Teo, W., Johnson, D.H., 2003. Wild-type and mutant myocilin co-expression causes heterodimer formation and intracellular retention of Please cite this article in press as: Johnson, M., Michael P. Fautsch, D j.exer.2008.11.009 wild-type protein without impairing proteasome function. In: Arvo Annual Meeting Abstract Search & Program Planner 2003 (abstract 1177). 78. Vrabel, A.M., Fautsch, M.P., Peterson, S.L., Johnson, D.H., 2003. Characterization of disulfide bonds in myocilin complex formation. In: Arvo Annual Meeting Abstract Search & Program Planner 2003 (abstract 1150). 79. Fautsch, M.P., Vrabel, A.M., Peterson, S.L., Johnson, D.H., 2003 Mar. Characterization of disulfide bond use in myocilin complex formation. FASEB J. 17 (4–5) (abstract 629.12). 80. Bahler, C.K., Johnson, D.H., Smedley, G.T., 2004 Apr. Trabecular bypass stents increase outflow facility in cultured human anterior segments. Investig. Ophthalmol. Vis. Sci. 45 (Suppl. 2), U434. 81. Fautsch, M.P., Vrabel, A.M., Bahler, C.K., Johnson, D.H., 2004 Apr. Aqueous humor supplementation enhances cultured trabecular cell protein expression profiles. Investig. Ophthalmol. Vis. Sci. 45 (Suppl. 2), U467. 82. Hann, C.R., Bahler, C.K., Johnson, D.H., 2004 Apr. Cationic ferritin and segmental flow through the trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 45 (Suppl. 2), U441. 83. Johnson, D.H., 27 Apr 2004. Trabecular meshwork and uveoscleral outflow models. Investig. Ophthalmol. Vis. Sci. Available from:ARVO (http://www.arvo.org) (E-abstract 2235). 84. Howell, K.G., Vrabel, A.M., Leontovich, A.A., Charlesworth, M.C., Muddiman, D.C., Raghavakaimal, S., Johnson, D.H., Fautsch, M.P., 2 May 2005. A comparison of gene and protein expression in primary human trabecular meshwork cells cultured with human aqueous humor or fetal bovine serum. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http:// www.arvo.org) (E-abstract 1345). 85. Scholz, M., Gottanka, J., Johnson, D.H., Lutjen-Drecoll, E., 2 May 2005. Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http:// www.arvo.org) (E-abstract 1274). 86. Fautsch, M.P., Bahler, C.K., Vrabel, A.M., Howell, K.G., Loewen, N., Poeschla, E.M., Johnson, D.H., 3 May 2005. Recombinant myocilin purified from human trabecular meshwork cells increases outflow resistance in human anterior segments but only in the presence of aqueous humor. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (Eabstract 2374). 87. Hann, C.R., Johnson, D.H., 4 May 2005. Focal adhesions are most prevalent in Schlemm’s canal and juxtacanalicular regions of the trabecular meshwork. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 3699). 88. Park, B.C., Shen, X., Fautsch, M.P., Tibudan, M., Johnson, D.H., Yue, B.Y.J.T. 4 May 2005. Optimized bacterial expression of myocilin proteins and functional comparison of bacterial and eukaryotic myocilins. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http//www.arvo.org) (E-abstract 3707). 89. Vrabel, A.M., Fautsch, M.P., Charlesworth, M.C., Madden, B., Muddiman, D.C., Johnson, D.H., 4 May 2005. Analysis of myocilin interactions in human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www. arvo.org) (E-abstract 3690). 90. Lim, K.S., Nau, C.B., Toris, C.B.A., Hodge, D., McLaren, J.W., Johnson. D.H., 5 May 2005. Mechanism of ocular hypotensive action of bimatoprost (Lumigan), Latanoprost (Xalatan) and Travoprost (Travatan) in normal subjects – a comparison of measurement techniques. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http//www.arvo.org) (E-abstract 4725). 91. Bahler, C.K., Howell, K.G., Hann, C.R., Fautsch, M.P., Johnson, D.H., 1 May 2006. Prostaglandins increase outflow facility in ouglas H. Johnson: A tribute, Exp. Eye. Res. (2009), doi:10.1016/ M. Johnson, M.P. Fautsch / Experimental Eye Research xxx (2009) 1–11 11 ARTICLE IN PRESS cultured human anterior segments. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 1845). 92. Fautsch, M.P., Howell, K.G., Leonovich, A.A., Raghavakaimal, S., Johnson, D.H., 1 May 2006. Global gene expression in primary trabecular cell monolayer culture is altered following incubation in human aqueous humor. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 1843). 93. Howell, K.G., Vrabel, A.M., Johnson, D.H., Fautsch. M.P., 1 May 2006. Myocilin levels are elevated in the aqueous of patients with POAG. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 1847). 94. Khare, P.D., Teo, W., Loewen, N., Barraza, R., Fautsch, M., Johnson, D.H., Poeschla, E.M., 4 May 2006. Long-term genetic modification of trabecular meshwork by lentiviral vectors: an 18 cat study. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 4770). 95. Sit, A.J., Nau, C.B., McLaren, J.W., Johnson, D.H., Hodge, D.O., 7 May 2006. Circadian variation of aqueous dynamics in adults 18–45 years old. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 1141). 96. Fautsch, M.P., Howell, K.G., Bahler, C.K., Leontovich, A.A., Raghavakaimal, S., Johnson, D.H., 7 May 2006. Time-course analysis of gene expression in trabecular meshwork following infusion of TGFb in organ culture. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (Eabstract1143). 97. Lei, Y., Garrahan, N., Johnson, D.H., Becker, D., Hernandez, M., Albon, J., Boulton, M., Morgan, J.E., 7 May 2006. Quantification of retina transneuronal changes in human glaucoma using a novel multiphoton-DAPI method. Investig. Ophthalmol. Vis. Please cite this article in press as: Johnson, M., Michael P. Fautsch, D j.exer.2008.11.009 Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 1555). 98. Howell, K.G., Leontovich, A.A., Raghavakaimal, S., Johnson, D.H., Fautsch, M.P., 7 May 2006. Elevated levels of TGFb cause unique gene expression changes in trabecular meshwork cells incubated in human aqueous humor. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (Eabstract 2060). 99. Hann, C.R., Johnson, D.H., 7 May 2006. Trabecular meshwork pigmentation and collector channels – areas of higher flow? Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http:// www.arvo.org) (E-abstract 2053). 100. Dzau, J.R., Lee, P.P., Herndon, L.W., Coleman, A.L., Johnson, D.H., 28 April 2008. Perceived causes of loss of vision in glaucoma from patient, family member, and eye care provider perspectives: a focus group study. Investig. Ophthalmol. Vis. Sci. Available from:ARVO (http://www.arvo.org) (E-abstract 1588). 101. Berdahl, J.P., Johnson, D.H., Allingham, R.R., 28 April 2008. Cerebrospinal fluid pressure is lower in primary open angle glaucoma. Investig. Ophthalmol. Vis. Sci. Available from: ARVO (http://www.arvo.org) (E-abstract 1599).